Related Experiment Video
Updated: Jul 1, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin1,2, Wenzhong Teng1,2, Yang Tian1,2
1State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Department of Laboratory Medicine, School of Public Health, Xiamen University, Xiamen, 361102, China.
Oncolytic virus (OV) immunotherapy shows promise for cancer treatment by targeting tumors. Overcoming the tumor microenvironment
Area of Science:
- Oncology
- Immunotherapy
- Virology
Background:
- Oncolytic virus (OV)-based immunotherapy is a promising cancer treatment strategy.
- The tumor microenvironment (TME) often suppresses immune responses, hindering OV effectiveness.
- Overcoming TME-induced immune resistance is critical for successful OV therapy.
Purpose of the Study:
- To review the potential of OV immunotherapy in modulating the TME.
- To explore how OVs can enhance antitumor immune responses.
- To discuss strategies for optimizing OV delivery and efficacy.
Main Methods:
- Review of current literature on OV immunotherapy and TME interactions.
- Analysis of OV roles in targeting immune cells (dendritic cells, T cells, NK cells, macrophages).
- Examination of OV-mediated TME alterations (angiogenesis inhibition, fibrosis reduction).
Main Results:
- OVs can modulate the immune landscape within the TME.
- OVs can target and influence various immune cell populations.
- Strategies exist to improve OV drug delivery and immunotherapy efficiency.
Conclusions:
- OV immunotherapy holds significant potential for cancer treatment.
- Modulating the TME is key to enhancing OV efficacy.
- Further optimization of OV-based strategies is crucial for clinical success.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

